APTON BIOSYSTEMS
Apton Biosystems develops an optical system designed for sequencing and protein detection, using super-resolution to assess molecules spaced closer than a wavelength of light. It enables biomarker discovery, early disease detection, and therapeutic monitoring, advancing preventive health and precision medicine.
APTON BIOSYSTEMS
Industry:
Biotechnology Genetics Health Care
Founded:
2012-01-01
Address:
Pleasanton, California, United States
Country:
United States
Website Url:
http://www.aptonbio.com
Total Employee:
11+
Status:
Active
Total Funding:
31.61 M USD
Technology used in webpage:
Domain Not Resolving Euro SPF IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare DNS
Similar Organizations
4D Molecular Therapeutics
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
ATOMsci
ATOMsci is a manufacturer of optoelectronic equipment that sells Raman spectrometers, photodetectors, lasers, and laser applications.
CODA Biotherapeutics
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
SeeDevice, Inc.
Quantum CMOS SWIR Image Sensor and Camera Technology
TeraImmune
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Scott Gorton CFO @ Apton Biosystems
CFO
Bryan Staker Chief Technology Officer @ Apton Biosystems
Chief Technology Officer
2012-08-01
Founder
Investors List
Kern Capital
Kern Capital investment in Series A - Apton Biosystems
Khosla Ventures
Khosla Ventures investment in Series A - Apton Biosystems
Casdin Capital
Casdin Capital investment in Series A - Apton Biosystems
Khosla Ventures
Khosla Ventures investment in Venture Round - Apton Biosystems
Official Site Inspections
http://www.aptonbio.com
- Host name: 172.67.151.47
- IP address: 172.67.151.47
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Apton Biosystems"
安腾瑞霖
Cell Culture Process Development Purification Process Development Formulation and Process Development Analytical Method DevelopmentSee details»
Who we are – Apton Biosystems - Mark and Carter
Geoff Smith, Ph.D. Board Member Geoff Smith, PhD is a leader in genomics technologies and applications. Geoff was Vice President of Technology Development at Illumina, where he …See details»
Apton Biosystems - LinkedIn
Apton Biosystems is a Pleasanton, California-based developer of Super-Res(TM) sequencing and single molecule protein detection systems. Apton has re-imagined the optical systems for …See details»
Apton Biosystems Company Profile 2024: Valuation, Investors
Information on acquisition, funding, cap tables, investors, and executives for Apton Biosystems. Use the PitchBook Platform to explore the full profile.See details»
Apton Biosystems - Craft
Apton Biosystems is a company that develops molecular profiling platform. Its platform allows healthcare industry players and medical professionals to provide biomarker discovery, early …See details»
Investors – Apton Biosystems - Mark and Carter
Apton has the unique, breakthrough technologies, and the brilliant, dedicated, driven people to bring the world the next generation of early cancer diagnostics.See details»
Aton Biotech - LinkedIn
Aton Biotech - A Henlius Company that is a fast-growing CDMO company which is committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform and …See details»
PacBio Enters into Agreement to Acquire Apton Biosystems to …
Aug 2, 2023 Apton has delivered with a lean and agile organization, and we look forward to fast-tracking the development of this new sequencer. Additionally, this comes at an opportune time …See details»
How we do it – Apton Biosystems - Mark and Carter
Apton can also sequence DNA using the same hardware stack. And because of Apton’s proprietary “self assembly” technology, flow cells are filled with DNA concatemers from a …See details»
KangaBio and Aton Biotech Enter Into Development and ... - PRWeb
Dec 20, 2022 "KangaBio is a biotech company focused on providing innovative medicine to address unmet medical needs. We are working on developing prodrugs of immune-stimulating …See details»
Aton: China backed CDMO with startup spirit - BioProcess Insider
Jan 19, 2023 With potentially 144,000 L of capacity and the experience of producing five of its own commercial products, Henlius recently launched Aton Biotech, a contract development …See details»
Creating Value As a CDMO - bioprocessintl.com
Nov 16, 2023 As a contract development and manufacturing organization (CDMO), Aton Biotech provides a comprehensive set of services to clients developing biological drugs. ... Number …See details»
KangaBio And Aton Biotech Enter Into Development And …
Dec 20, 2022 <p>Aton Biotech, a fast-growing CDMO company which is committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio …See details»
What sets the best CDMOs apart is their ability to consistently ...
Sep 18, 2024 BioProcess International article with Aton Biotech’s Chief Business Officer, Min Park, MBA on Creating Value as a CDMO. Customer-Centric Mindset I’ve been in the life …See details»
What we do – Apton Biosystems
Searching for a needle hidden among hundreds of haystacks is child’s play compared to finding a single cancer molecule in a blood sample. But Apton can find it.See details»
Aton: future proofing key to CDMO success - BioProcess Insider
Jul 31, 2023 It is critical to future proof an organization to meet changing customer demands, says CDMO Aton Bio. In January, Shanghai Henlius Biotech launched contract development …See details»
PacBio Enters into Agreement to Acquire Apton Biosystems to …
Aug 3, 2023 PacBio will Combine Apton’s Proprietary Sequencing Technology With its Highly Accurate Sequencing by Binding Chemistry to Develop a High-Throughput Sequencer …See details»
Apton Biosystems Raises $24M in Series A Funding
Jun 30, 2021 NEW YORK – Apton Biosystems, a Pleasanton, California-based firm developing sequencing and protein detection technology, said on Wednesday that it has raised $24 million …See details»
BioProcess Insider Interview: Min Park, Chief Business Officer, Aton ...
Aug 21, 2023 Moderator: Millie Nelson, Editor, BioProcess Insider. Featuring: Min Park, Chief Business Officer, Aton Biotech. In an industry with no shortage of contract development and …See details»
3 Key Trends shaping the CDMO industry - LinkedIn
Sep 16, 2024 Contract Pharma Interview with Aton Biotech’s Chief Business Officer, Min Park, MBA with what are “3 Key Trends” shaping the CDMO industry in 2023 and beyond? …See details»